セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/03/10 | 3,500 | 3,530 | 3,400 | 3,420 | -75 | -2.1% | 113,400 |
| 2023/03/09 | 3,495 | 3,515 | 3,440 | 3,495 | ±0 | ±0% | 104,200 |
| 2023/03/08 | 3,605 | 3,615 | 3,485 | 3,495 | -135 | -3.7% | 196,100 |
| 2023/03/07 | 3,685 | 3,710 | 3,620 | 3,630 | -20 | -0.5% | 65,300 |
| 2023/03/06 | 3,680 | 3,740 | 3,650 | 3,650 | +30 | +0.8% | 110,600 |
| 2023/03/03 | 3,560 | 3,640 | 3,560 | 3,620 | +60 | +1.7% | 78,000 |
| 2023/03/02 | 3,580 | 3,590 | 3,505 | 3,560 | -55 | -1.5% | 99,700 |
| 2023/03/01 | 3,675 | 3,675 | 3,575 | 3,615 | -90 | -2.4% | 141,500 |
| 2023/02/28 | 3,600 | 3,740 | 3,600 | 3,705 | +115 | +3.2% | 127,500 |
| 2023/02/27 | 3,560 | 3,640 | 3,545 | 3,590 | -15 | -0.4% | 87,400 |
| 2023/02/24 | 3,560 | 3,620 | 3,460 | 3,605 | +45 | +1.3% | 94,100 |
| 2023/02/22 | 3,535 | 3,580 | 3,515 | 3,560 | -40 | -1.1% | 66,400 |
| 2023/02/21 | 3,685 | 3,685 | 3,585 | 3,600 | -60 | -1.6% | 68,500 |
| 2023/02/20 | 3,595 | 3,675 | 3,570 | 3,660 | +110 | +3.1% | 97,200 |
| 2023/02/17 | 3,535 | 3,610 | 3,520 | 3,550 | -15 | -0.4% | 50,300 |
| 2023/02/16 | 3,500 | 3,590 | 3,470 | 3,565 | +65 | +1.9% | 53,500 |
| 2023/02/15 | 3,510 | 3,555 | 3,455 | 3,500 | ±0 | ±0% | 70,200 |
| 2023/02/14 | 3,590 | 3,605 | 3,490 | 3,500 | -50 | -1.4% | 65,400 |
| 2023/02/13 | 3,550 | 3,570 | 3,510 | 3,550 | -40 | -1.1% | 84,400 |
| 2023/02/10 | 3,725 | 3,725 | 3,570 | 3,590 | -145 | -3.9% | 124,800 |
| 2023/02/09 | 3,750 | 3,750 | 3,680 | 3,735 | -15 | -0.4% | 64,200 |
| 2023/02/08 | 3,690 | 3,750 | 3,610 | 3,750 | +75 | +2% | 90,000 |
| 2023/02/07 | 3,655 | 3,680 | 3,625 | 3,675 | +45 | +1.2% | 46,500 |
| 2023/02/06 | 3,600 | 3,675 | 3,580 | 3,630 | +30 | +0.8% | 70,900 |
| 2023/02/03 | 3,660 | 3,660 | 3,580 | 3,600 | -10 | -0.3% | 51,600 |
| 2023/02/02 | 3,605 | 3,660 | 3,605 | 3,610 | -20 | -0.6% | 73,600 |
| 2023/02/01 | 3,670 | 3,690 | 3,620 | 3,630 | ±0 | ±0% | 56,000 |
| 2023/01/31 | 3,645 | 3,665 | 3,555 | 3,630 | -40 | -1.1% | 112,500 |
| 2023/01/30 | 3,745 | 3,745 | 3,640 | 3,670 | -5 | -0.1% | 80,800 |
| 2023/01/27 | 3,690 | 3,790 | 3,660 | 3,675 | +15 | +0.4% | 133,200 |
| 2023/01/26 | 3,700 | 3,725 | 3,610 | 3,660 | -20 | -0.5% | 89,800 |
| 2023/01/25 | 3,645 | 3,775 | 3,585 | 3,680 | +35 | +1% | 199,900 |
| 2023/01/24 | 3,565 | 3,650 | 3,525 | 3,645 | +145 | +4.1% | 156,600 |
| 2023/01/23 | 3,410 | 3,510 | 3,370 | 3,500 | +100 | +2.9% | 137,500 |
| 2023/01/20 | 3,460 | 3,475 | 3,390 | 3,400 | -95 | -2.7% | 181,800 |
| 2023/01/19 | 3,590 | 3,590 | 3,470 | 3,495 | -65 | -1.8% | 128,300 |
| 2023/01/18 | 3,555 | 3,645 | 3,535 | 3,560 | ±0 | ±0% | 125,100 |
| 2023/01/17 | 3,650 | 3,650 | 3,540 | 3,560 | -120 | -3.3% | 126,000 |
| 2023/01/16 | 3,555 | 3,725 | 3,555 | 3,680 | +80 | +2.2% | 131,100 |
| 2023/01/13 | 3,620 | 3,620 | 3,480 | 3,600 | -10 | -0.3% | 188,500 |
| 2023/01/12 | 3,650 | 3,700 | 3,595 | 3,610 | -10 | -0.3% | 102,100 |
| 2023/01/11 | 3,675 | 3,725 | 3,620 | 3,620 | -20 | -0.5% | 162,100 |
| 2023/01/10 | 3,700 | 3,725 | 3,560 | 3,640 | +5 | +0.1% | 154,800 |
| 2023/01/06 | 3,645 | 3,680 | 3,580 | 3,635 | -60 | -1.6% | 123,200 |
| 2023/01/05 | 3,740 | 3,780 | 3,655 | 3,695 | -40 | -1.1% | 141,900 |
| 2023/01/04 | 3,880 | 3,940 | 3,700 | 3,735 | -270 | -6.7% | 212,400 |
| 2022/12/30 | 3,875 | 4,115 | 3,860 | 4,005 | +170 | +4.4% | 211,400 |
| 2022/12/29 | 3,870 | 3,950 | 3,820 | 3,835 | -40 | -1% | 131,200 |
| 2022/12/28 | 3,920 | 3,970 | 3,835 | 3,875 | -60 | -1.5% | 131,000 |
| 2022/12/27 | 3,805 | 3,985 | 3,790 | 3,935 | +165 | +4.4% | 222,500 |
301～
350
件表示中 / 1121件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 127,500円 | +19.0% | -13.1% | 0.39% | 35.12倍 | 4.11倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 344,000円 | -5.1% | -21.2% | 4.65% | 10.86倍 | 2.09倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ステムリム | 46,300円 | -14.9% | -31.0% | 0.00% | 189.75倍 | 3.32倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 扶桑薬 | 229,900円 | +2.9% | +23.1% | 3.48% | 11.56倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| 大幸薬品 | 36,800円 | +11.1% | - | 0.00% | 33.58倍 | 2.74倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
